| Test Code |
Test Name |
| YSTC |
CULTURE, YEAST ONLY |
|
|
| YERC |
CULTURE, YERSINIA |
|
|
| WNDCS |
CULTURE, WOUND SUPERFICIAL |
|
|
| WNDCD |
CULTURE, WOUND DEEP |
|
|
| VREC |
CULTURE, VANCOMYCIN RESISTANT ENTEROCOCCUS |
|
|
| VIBRC |
CULTURE, VIBRIO |
|
|
| VCUNR |
Culture, Viral, Non-Respiratory, Conventional, Body Fluids or Tissue |
|
|
| UNCMS |
CARRIER SCREEN, 274 CONDITIONS |
|
|
| UNCMS |
COVID-19 ANTI-NUCLEOCAPSID IgG, QUAL (infection) |
|
|
| UCOPR |
Copper, Random Urine |
|
|
| UCDRG |
Comprehensive Drug Screen, Umbilical Cord Tissue |
|
|
| UCATX |
Catecholamines, Fractionated, 24-Hour Urine with Creatinine |
|
|
| UC |
CULTURE, URINE |
|
|
| TISS |
CULTURE, TISSUE |
|
|
| TIPC |
CULTURE, CATHETER TIP |
|
|
| THBC |
CULTURE, THROAT GROUP A (BETA) STREP ONLY |
|
|
| STI3 |
Chlamydia Trachomatis (CT), Neisseria Gonorrhoeae (NG), Trichomonas Vaginalis (TV) by PCR |
|
|
| STI2 |
Chlamydia Trachomatis (CT), Neisseria Gonorrhoeae (NG) by PCR |
|
|
| SPUTC |
CULTURE, SPUTUM |
|
|
| SINUC |
CULTURE, SINUS |
|
|
| SAPSC |
CULTURE, STAPH AUREUS PRESURGICAL SCREEN |
|
|
| RESC |
CULTURE, RESPIRATORY LOWER |
|
|
| PGBSC |
CULTURE, STREP GROUP B, (VAGINAL) PENICILLIN ALLERGY |
|
|
| PCHEP |
Cholinesterase, Serum |
|
|
| PAPTS and PAPGN (PTSH Orderable in Soft Path Only) |
CYTOLOGY, THIN PREP® PAP SMEAR, SCREENING, WITH HPV |
|
|
| PAPTS |
CYTOLOGY, THIN PREP® PAP SMEAR, SCREENING |
|
|
| PAPTD and PAPGN (PTDH Orderable in Soft Path Only) |
CYTOLOGY, THIN PREP® PAP SMEAR, DIAGNOSTIC, WITH HPV |
|
|
| PAPTD |
CYTOLOGY, THIN PREP® PAP SMEAR, DIAGNOSTIC |
|
|
| P450 |
Cytochrome P450 2C9 Genotype |
|
|
| NTX24 |
Collagen Cross-Linked N-Telopeptide (NTx), 24-Hour Urine |
|
|
| NOSC |
CULTURE, NOSE |
|
|
| NCRCL |
CREATININE CLEARANCE |
|
|
| NBFCC |
CELL COUNT WITH DIFFERENTIAL, BODY FLUID |
|
|
| NAPHC |
CULTURE, NASOPHARYNGEAL |
|
|
| MRSAC |
CULTURE, MRSA |
|
|
| MDERC |
CULTURE, MIDDLE EAR FLUID |
|
|
| MCPOC |
Chromosomal Microarray, POC, ClariSure® Oligo-SNP |
|
|
| KPCSC |
CULTURE, CARBAPENEMASE RESISTANT ENTEROBACTERIACIAE (CRE) SCREEN |
|
|
| KITGI |
c-KIT Mutations with Reflex to PDGFRA Mutations for GIST |
|
|
| IGVMS |
Chronic Lymphocytic Leukemia, IgVH Mutation Status, Cell-based |
|
|
| HSCRP |
C REACTIVE PROTEIN, HIGH SENSITIVITY |
|
|
| GENC |
CULTURE, GENITAL |
|
|
| GC |
CULTURE, GONORRHEA |
|
|
| GBSC |
CULTURE, STREP GROUP B (VAGINAL) |
|
|
| FUNSC |
CULTURE, FUNGUS SKIN |
|
|
| FUNNC |
CULTURE, FUNGUS NAIL |
|
|
| FUNHC |
CULTURE, FUNGUS HAIR |
|
|
| FUNC |
CULTURE, FUNGUS |
|
|
| FUNBM |
CULTURE, FUNGUS BONE MARROW |
|
|
| FUNBC |
CULTURE, FUNGUS BLOOD |
|
|
| FLWCY |
CHRONIC LYMPHOPROLIFERATIVE PANEL BY FLOW CYTOMETRY |
|
|
| FEC |
CULTURE, FECES |
|
|
| EYEVC |
CULTURE, EYE VITREOUS FLUID |
|
|
| EYEC |
CULTURE, EYE |
|
|
| EYEAC |
CULTURE, EYE AQUEOUS FLUID |
|
|
| ENVDC |
CULTURE, DIALYSIS ENVIRONMENTAL |
|
|
| ENVC |
CULTURE, ENVIRONMENTAL |
|
|
| EARC |
CULTURE, EAR |
|
|
| DMCOC |
COCAINE CONFIRMATION |
|
|
| CYSCF |
Cysticercus Antibody (IgG), ELISA CSF |
|
|
| CYSCE |
Cystatin C with Glomerular Filtration Rate, Estimated (eGFR) |
|
|
| CYSAB |
Cysticercus Antibody (IgG), ELISA, Serum |
|
|
| CYREQ |
CUL DE SAC FLUIDS/PERITONEAL WASHINGS, GUTTER WASHINGS FOR CYTOLOGY |
|
|
| CYREQ |
CYTOLOGY, BILE (SHUNT FLUID) |
|
|
| CYREQ |
CYTOLOGY, BLADDER WASHING |
|
|
| CYREQ |
CYTOLOGY, BODY FLUID |
|
|
| CYREQ |
CYTOLOGY, BREAST FLUID |
|
|
| CYREQ |
CYTOLOGY, BREAST SMEAR/NIPPLE DISCHARGE |
|
|
| CYREQ |
CYTOLOGY, BRONCHIAL BRUSH |
|
|
| CYREQ |
CYTOLOGY, BRONCHIAL WASHES / LAVAGES |
|
|
| CYREQ |
CYTOLOGY, COLONIC / DUODENAL BRUSH |
|
|
| CYREQ |
CYTOLOGY, FINE NEEDLE ASPIRATION |
|
|
| CYREQ |
CYTOLOGY, URINE |
|
|
| CYREQ |
CYTOLOGY, SPINAL FLUID |
|
|
| CYREQ |
CYTOLOGY, SPUTUM |
|
|
| CYCTP |
CYCLIC CITRULLINATED PEPTIDE, ANTIBODIES |
|
|
| CYCSM |
CYCLOSPORA/CYSTO ISOSPORA SMEAR |
|
|
| CYCLO |
CYCLOSPORINE, WHOLE BLOOD |
|
|
| CYAN |
Cyanide, Blood |
|
|
| CUTIM |
Cutaneous Direct Immunofluorescence [18899X] |
|
|
| CURBC |
Copper, RBC |
|
|
| CUP2 |
Chronic Urticaria Panel 2 (Comprehensive) |
|
|
| CTX |
Collagen Type I C-Telopeptide (CTx) |
|
|
| CTPCR |
Chlamydia Trachomatis by PCR |
|
|
| CSTRU |
Cystine, Random Urine with Creatinine |
|
|
| CST24 |
Cystine, 24-Hour Urine [10947X] |
|
|
| CSONE |
Cortisone, Serum |
|
|
| CSFCC |
CELL COUNT WITH DIFFERENTIAL, CSF |
|
|
| CSFC |
CULTURE, CSF |
|
|
| CRYQL |
CRYOGLOBULINS |
|
|
| CRYPT |
CRYPTOCOCCUS ANTIGEN, SERUM |
|
|
| CRYCF |
CRYPTOCOCCUS ANTIGEN, CSF |
|
|
| CRYBF |
CRYSTAL IDENTIFICATION |
|
|
| CRPQT |
C REACTIVE PROTEIN, QUANTITATIVE |
|
|
| CRNFT |
Carnitine |
|
|
| CRFU2 |
CORTISOL FREE, URINE, 24 HOUR |
|
|
| CREUR |
CREATININE, URINE, RANDOM |
|
|
| CREBF |
CREATININE, BODY FLUID |
|
|
| CRE |
CREATININE |
|
|
| CR24U |
CREATININE, URINE, 24 HOUR |
|
|
| CR/UN |
CREATININE AND UREA NITROGEN, 24HR URINE |
|
|
| CPU24 |
Copper, 24-Hour Urine with Creatinine |
|
|
| CPTHC |
CULTURE, THROAT COMPREHENSIVE |
|
|
| CPEPT |
C PEPTIDE |
|
|
| CPBRG |
Chromosome Analysis, Blood with reflex to Postnatal ClariSure® Oligo-SNP Array |
|
|
| CP2D6 |
Cytochrome P450 2D6 Genotype |
|
|
| COXA1 |
Coxsackie A Antibodies, Serum |
|
|
| COVMA |
COVID-19 ANTI-SPIKE IgM, QUAL (inf/vacc) |
|
|
| COVGA |
COVID-19 ANTI-SPIKE IgG, QUAL (inf/vacc/mAB) |
|
|
| COSWC |
COCAINE METABOLITE SCREEN, w/ CONFIRMATION |
|
|
| CORUR |
CORTISOL, URINE, RANDOM |
|
|
| CORSL |
Cortisol, LC/MS, Saliva |
|
|
| CORRN |
CORTISOL, RANDOM |
|
|
| CORPN |
CORTISOL, 4 PM |
|
|
| CORNC |
CULTURE, CORNEA RIM |
|
|
| CORB |
CORTISOL, BASELINE |
|
|
| CORAN |
CORTISOL, 8 AM |
|
|
| COQ10 |
Coenzyme Q10 |
|
|
| COPPR |
Copper |
|
|
| COPEP |
Copeptin |
|
|
| CONS |
CONJUNCTIVAL SMEAR |
|
|
| COMC5 (354) |
Complement C5, Concentration |
|
|
| COLOV |
ColoVantage® (Methylated Septin 9) |
|
|
| COHGB |
Carboxyhemoglobin, Blood |
|
|
| COFLU |
COVID-19, INFLUENZA A/B PANEL by PCR |
|
|
| COCIM |
Coccidioides Antibodies (IgG, IgM), Immunodiffusion |
|
|
| COCAP |
Coccidioides Antibody Panel, Complement Fixation and Immunodiffusion, CSF |
|
|
| COCAM |
Cocaine and Metabolites, Confirmation, Serum Plasma, or Blood [11328X] |
|
|
| COBLT |
Cobalt, Serum/Plasma |
|
|
| CO2 |
CARBON DIOXIDE |
|
|
| CO19S |
COVID-19 by PCR, RISK ASSESSMENT for HOSPITALS |
|
|
| CO19H |
COVID-19 HIGH SENSITIVITY by PCR |
|
|
| CND4V |
Canavan Disease Mutation Analysis |
|
|
| CMVQP |
CYTOMEGALOVIRUS, DNA by PCR, QUANTITATIVE (Viral Load) |
|
|
| CMVQL |
CYTOMEGALOVIRUS, DNA by PCR, QUALITATIVE |
|
|
| CMVPS |
Cytomegalovirus DNA, Qualitative Real-Time PCR, Saliva |
|
|
| CMVM |
CYTOMEGALOVIRUS, IGM |
|
|
| CMVGM |
CYTOMEGALOVIRUS, PANEL IGG & IGM |
|
|
| CMVG2 |
CYTOMEGALOVIRUS, IGG |
|
|
| CMVCR |
Cytomegalovirus, Rapid Culture [17511X] |
|
|
| CMP2 |
COMPREHENSIVE METABOLIC 14 |
|
|
| CMG |
Creatine, Serum |
|
|
| CLUR6 |
CHLORIDE, RANDOM URINE, w/ out CREATININE |
|
|
| CLUR |
CHLORIDE, URINE, RANDOM |
|
|
| CLUN |
CHLORIDE, URINE, 24 HOUR |
|
|
| CLOZA |
Clozapine |
|
|
| CLOR |
Clorazepate (Tranxene®) |
|
|
| CLON |
Clonazepam |
|
|
| CLOBM |
Clobazam and Metabolite, Serum/Plasma |
|
|
| CLO |
CLOTEST for HELICOBACTER PYLORI |
|
|
| CLLFH |
CHRONIC LYMPHOCYTIC LEUKEMIA / SMALL LYMPHOCYTIC LYMPHOMA PANEL by FISH |
|
|
| CLCSF |
Chloride, CSF |
|
|
| CL |
CHLORIDE |
|
|
| CKIT |
c-kit Mutation Analysis, Cell-based |
|
|
| CKIEZ |
Creatine Kinase Isoenzymes (CK Isoenzymes) with Total CK |
|
|
| CK |
CREATINE KINASE - NAC |
|
|
| CIT-S |
Citric Acid, Serum |
|
|
| CIA24 |
Citric Acid, 24-Hour Urine with Creatinine |
|
|
| CHRPB |
Chromosome Analysis, Blood |
|
|
| CHROM |
CHROMATIN |
|
|
| CHRM |
Chromium, Serum |
|
|
| CHRCL |
Chromosome Analysis, CLL/LPD |
|
|
| CHORP |
Cholinesterase, RBC and Plasma |
|
|
| CHOPT |
CHOLESTEROL, PERITONEAL FLUID |
|
|
| CHOPF |
CHOLESTEROL, PLEURAL FLUID |
|
|
| CHOL |
CHOLESTEROL |
|
|
| CHMRU |
Chromium, Urine |
|
|
| CHMPC |
Chromosome Analysis, Tissue |
|
|
| CHMIC |
Chromosomal Microarray, Postnatal, ClariSure® Oligo-SNP |
|
|
| CHLYM |
Chromosome Analysis, Lymph Node |
|
|
| CHLRP |
Chlorpromazine, Serum/Plasma |
|
|
| CHLMC |
Chlamydiae Species Culture |
|
|
| CHLIM |
Chlamydia and Chlamydophila Antibody Panel 2 (IgM) |
|
|
| CHLAB |
Chlamydia/Chlamydophila Antibody Panel 3 (IgG, IgA, IgM) |
|
|
| CHGA |
Chromogranin A, LC/MS/MS |
|
|
| CHFLA |
Chromosome Analysis,Amniotic Fluid Reflex to ClariSure®,Oligo-SNP,Prenatal |
|
|
| CHAST |
Chromosome Analysis, Solid Tumor |
|
|
| CHABM |
Chromosome Analysis, Hematologic Malignancy |
|
|
| CHAB4 |
Chlamydia/Chlamydophila Antibody Panel (IgG, IgM) |
|
|
| CHAAF |
Chromosome Analysis, Amniotic Fluid |
|
|
| CH50 |
Complement, Total (CH50) |
|
|
| CH24U |
Chromium, 24-Hour Urine [10944X] |
|
|
| CFSCR |
CFvantage® Cystic Fibrosis Expanded Screen |
|
|
| CFLUP |
COVID-19, FLU A/B, RSV PANEL by PCR |
|
|
| CF24U |
Cortisol, Free, 24-Hour Urine w/ Creatinine by LCMS |
|
|
| CERUL |
CERULOPLASMIN |
|
|
| CENT |
CENTROMERE B ANTIBODY |
|
|
| CELIN |
CELIAC DISEASE PANEL, INFANT DIAGNOSTIC |
|
|
| CELAD |
CELIAC DISEASE PANEL, (Greater than 2 years old) |
|
|
| CEBPA |
CEBPA Mutation Analysis |
|
|
| CEAPT |
CEA, PERITONEAL FLUID |
|
|
| CEAPL |
CEA, PLEURAL FLUID |
|
|
| CEAPC |
CEA, Carcinoembryonic Antigen, Pancreatic Cyst Fluid |
|
|
| CEA |
CEA |
|
|
| CDPCR |
CLOSTRIDIUM DIFFICILE TOXIN B, PCR |
|
|
| CDMRU |
Cadmium, Random Urine |
|
|
| CDFC1 |
Clostridium difficile Culture with Reflex to Toxin B, Real Time PCR, Isolate |
|
|
| CDF2 |
CLOSTRIDIUM DIFFICILE GDH / TOXIN by EIA w/ REFLEX to PCR |
|
|
| CDCYT |
Clostridium difficile Cytotoxicity Assay |
|
|
| CD4CT |
CD4 COUNT |
|
|
| CD48C |
CD4 & CD8 COUNT |
|
|
| CD24U |
Cadmium, 24-Hour Urine |
|
|
| CCFID |
Coccidioides Antibody, CF and ID, Serum [15240X] |
|
|
| CCF24 |
Cortisol, Free and Cortisone, 24-Hour Urine with Creatinine |
|
|
| CBFBT |
Carbamazepine and Metabolite, Free/Bound/Total |
|
|
| CBCMN |
CBC w/ ORDERED MANUAL DIFFERENTIAL |
|
|
| CBCBT |
CBC, BLUE TOP RECOLLECTION |
|
|
| CBC3 |
CBC w/ DIFFERENTIAL |
|
|
| CAUSC |
CANDIDA AURIS SCREEN |
|
|
| CAUR |
CALCIUM, URINE, RANDOM |
|
|
| CAUN |
CALCIUM, URINE, 24 HOUR |
|
|
| CATPF |
Catecholamines, Fractionated, Plasma [314X] |
|
|
| CATFU |
Catecholamines, Fractionated, Random Urine |
|
|
| CASWC |
CANNABINOID SCREEN w/ CONFIRMATION |
|
|
| CARP |
CARDIAC PROFILE |
|
|
| CAROT |
Carotene |
|
|
| CARMQ |
Carisoprodol and Metabolite, Urine |
|
|
| CARL2 |
CARDIOLIPIN ANTIBODY IGG, IGM, & IGA PANEL |
|
|
| CARGM |
CARDIOLIPIN ANTIBODY, IGM |
|
|
| CARGG |
CARDIOLIPIN ANTIBODY, IGG |
|
|
| CARGA |
CARDIOLIPIN ANTIBODY, IGA |
|
|
| CARB |
CARBAMAZEPINE |
|
|
| CALPR |
CALPROTECTIN, FECAL |
|
|
| CALMA |
Calreticulin (CALR) Mutation Analysis |
|
|
| CALCI |
CALCIUM, IONIZED, SERUM OR PLASMA |
|
|
| CALC |
Calcitonin |
|
|
| CAGM2 |
CARDIOLIPIN ANTIBODY IGG & IGM PANEL |
|
|
| CAGG |
COLD AGGLUTININS |
|
|
| CAFF |
Caffeine |
|
|
| CAEPT |
Carbamazepine-10,11-Epoxide, Serum/Plasma |
|
|
| CADM |
Cadmium, Blood |
|
|
| CACRR |
CALCIUM / CREATININE RATIO, URINE, RANDOM |
|
|
| CAAGM |
Candida albicans Antibodies (IgG, IgA, IgM) |
|
|
| CA199 |
CANCER ANTIGEN 19 9 |
|
|
| CA153 |
CANCER ANTIGEN 15 3 |
|
|
| CA125 |
CANCER ANTIGEN 125 |
|
|
| CA |
CALCIUM |
|
|
| C4 |
COMPLEMENT, C4 |
|
|
| C3 |
COMPLEMENT, C3 |
|
|
| C2729 |
CANCER ANTIGEN 27 29 |
|
|
| C1QCC |
Complement Component C1q |
|
|
| C1INP |
C1 Esterase Inhibitor, Protein |
|
|
| C1INF |
C1 Esterase Inhibitor, Functional |
|
|
| BRONC |
CULTURE, BRONCHIAL |
|
|
| BMARC |
CULTURE, BONE MARROW |
|
|
| BFC |
CULTURE, BODY FLUID |
|
|
| BCPJT |
CULTURE, BACTERIAL, PROSTHETIC JOINT REVISION |
|
|
| BC |
CULTURE, BLOOD |
|
|
| BBC |
CULTURE, TRANSFUSION REACTION |
|
|
| ANCYT |
CYTOLOGY, THIN PREP®, ANAL PAP |
|
|
| ANAF |
Clomipramine |
|
|
| ANAC |
CULTURE, ANAEROBIC |
|
|
| AGCWM |
Cow's Milk (f2) IgG |
|
|
| AGCHK |
Chicken Meat (f83) IgG |
|
|
| AFBWD |
CULTURE, AFB WOUND |
|
|
| AFBTS |
CULTURE, AFB TISSUE |
|
|
| AFBB |
CULTURE, AFB BLOOD |
|
|
| AFB |
CULTURE, AFB OTHER |
|
|
| ACLHE |
Cladosporium herbarum (m2) IgE [2702X] |
|
|
| ACATF |
Catfish (f369) IgE |
|
|
|
|
